Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Current Leases: 2023-2025

Historic Current Leases for CG Oncology (CGON) over the last 2 years, with Sep 2025 value amounting to $912,000.

  • CG Oncology's Current Leases rose 305.33% to $912,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $912,000, marking a year-over-year increase of 305.33%. This contributed to the annual value of $186,000 for FY2024, which is 14.29% down from last year.
  • As of Q3 2025, CG Oncology's Current Leases stood at $912,000, which was up 216.67% from $288,000 recorded in Q2 2025.
  • CG Oncology's Current Leases' 5-year high stood at $912,000 during Q3 2025, with a 5-year trough of $186,000 in Q4 2024.
  • Moreover, its 3-year median value for Current Leases was $231,000 (2024), whereas its average is $317,500.
  • Its Current Leases has fluctuated over the past 5 years, first declined by 14.29% in 2024, then skyrocketed by 305.33% in 2025.
  • Quarterly analysis of 3 years shows CG Oncology's Current Leases stood at $217,000 in 2023, then declined by 14.29% to $186,000 in 2024, then skyrocketed by 305.33% to $912,000 in 2025.
  • Its last three reported values are $912,000 in Q3 2025, $288,000 for Q2 2025, and $255,000 during Q1 2025.